# TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

> **NCT03574324** · PHASE3 · UNKNOWN · sponsor: **Guiyang Medical University** · enrollment: 266 (estimated)

## Conditions studied

- Locally Advanced Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** TPF+CCRT
- **DRUG:** CCRT+PF

## Key facts

- **NCT ID:** NCT03574324
- **Lead sponsor:** Guiyang Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-24
- **Primary completion:** 2023-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03574324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03574324, "TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03574324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*